Pramipexole
ATC N04BC05 · 9 markets · 499 records
GB 233 records · 7 strengths
- 2.1 mgtablet · extended-releaseMirapexin 0.26mg modified-release tabletsOprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、__no_trade__
- 1.05 mgtablet · extended-releaseMirapexin 0.26mg modified-release tabletsOprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、__no_trade__
- 2.62 mgtablet · extended-releaseMirapexin 0.26mg modified-release tabletsOprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、Sifrol 2.62mg modified-release tablets、__no_trade__
- 1.57 mgtablet · extended-releaseMirapexin 0.26mg modified-release tabletsOprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、__no_trade__
- 3.15 mgtablet · extended-releaseMirapexin 0.26mg modified-release tabletsOprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、__no_trade__
Records without a stated strength · 2 Mirapexin 0.26mg modified-release tablets、Oprymea 0.26mg modified-release tablets、Pipexus 1.05mg modified-release tablets、__no_trade__ Mirapexin 0.7mg tablets、Neliprax 0.088mg tablets、Oprymea 0.088mg tablets、__no_trade__
CN 89 records · 5 strengths
- 0.375 mgtablet · extended-release森福罗盐酸普拉克索__mah__:MacleodsPharmaceuticalsLtd、__mah__:力品药业(厦门)股份有限公司、__mah__:北京北大维信生物科技有限公司、__mah__:北京北陆药业股份有限公司、__mah__:天津红日药业股份有限公司、__mah__:山东华铂凯盛生物科技有限公司、__mah__:成都倍特药业股份有限公司、__mah__:成都康弘药业集团股份有限公司 +9
- 0.75 mgtablet · extended-release森福罗盐酸普拉克索__mah__:MacleodsPharmaceuticalsLtd、__mah__:力品药业(厦门)股份有限公司、__mah__:北京北大维信生物科技有限公司、__mah__:北京北陆药业股份有限公司、__mah__:山东华铂凯盛生物科技有限公司、__mah__:成都百裕制药股份有限公司、__mah__:江苏恒瑞医药股份有限公司、__mah__:浙江京新药业股份有限公司 +3
- 1.5 mgtablet · extended-releaseManufacturer: MacleodsPharmaceuticalsLtd ×3__mah__:北京北大维信生物科技有限公司、__mah__:天津红日药业股份有限公司、__mah__:成都倍特药业股份有限公司、__mah__:成都康弘药业集团股份有限公司、__mah__:成都百裕制药股份有限公司、__mah__:海思科制药(眉山)有限公司、__mah__:石药集团欧意药业有限公司
- 0.25 mgtablet森福罗盐酸普拉克索__mah__:天津红日药业股份有限公司、__mah__:浙江京新药业股份有限公司、__mah__:石药集团欧意药业有限公司、__mah__:齐鲁制药(海南)有限公司
- 1 mgtablet森福罗盐酸普拉克索__mah__:天津红日药业股份有限公司、__mah__:浙江京新药业股份有限公司、__mah__:石药集团欧意药业有限公司、__mah__:齐鲁制药(海南)有限公司
ES 70 records · 12 strengths
- 2.1 mgtablet · extended-releaseMirapexin 0.7mg tabletsOprymea 0.088mg tablets、PRAMIPEXOL AUROVITAS SPAIN、PRAMIPEXOL CINFA、PRAMIPEXOL KERN PHARMA、PRAMIPEXOL NORMON、PRAMIPEXOL PENSA、PRAMIPEXOL RATIOPHARM、PRAMIPEXOL SANDOZ FARMACEUTICA +1
- 1.05 mgtablet · extended-releaseMirapexin 0.7mg tabletsOprymea 0.088mg tablets、PRAMIPEXOL AUROVITAS SPAIN、PRAMIPEXOL CINFA、PRAMIPEXOL KERN PHARMA、PRAMIPEXOL NORMON、PRAMIPEXOL PENSA、PRAMIPEXOL RATIOPHARM、PRAMIPEXOL SANDOZ FARMACEUTICA +1
- 0.26 mgtablet · extended-releaseMirapexin 0.7mg tabletsOprymea 0.088mg tablets、PRAMIPEXOL AUROVITAS SPAIN、PRAMIPEXOL CINFA、PRAMIPEXOL KERN PHARMA、PRAMIPEXOL NORMON、PRAMIPEXOL PENSA、PRAMIPEXOL SANDOZ FARMACEUTICA、PRAMIPEXOL TEVA-RATIOPHARM
- 2.62 mgtablet · extended-releaseOprymea 0.088mg tabletsPRAMIPEXOL CINFA、PRAMIPEXOL NORMON
- 1.57 mgtablet · extended-releaseOprymea 0.088mg tabletsPRAMIPEXOL CINFA、PRAMIPEXOL NORMON
- 0.18 mgtabletMirapexin 0.7mg tabletsOprymea 0.088mg tablets、PRAMIPEXOL KERN PHARMA、PRAMIPEXOL NORMON、PRAMIPEXOL PENSA、PRAMIPEXOL STADA、PRAMIPEXOL TEVA
- 3.15 mgtablet · extended-releaseOprymea 0.088mg tabletsPRAMIPEXOL NORMON
- 0.7 mgtabletMirapexin 0.7mg tabletsOprymea 0.088mg tablets、PRAMIPEXOL KERN PHARMA、PRAMIPEXOL NORMON、PRAMIPEXOL STADA、PRAMIPEXOL TEVA
- 0.52 mgtablet · extended-releaseOprymea 0.088mg tabletsPRAMIPEXOL CINFA、PRAMIPEXOL NORMON
- 0.7 mg/1 tablettabletPRAMIPEXOL AUROVITASPRAMIPEXOL CINFA
- 0.18 mg/1 tablettabletPRAMIPEXOL AUROVITASPRAMIPEXOL CINFA
- 3.15 mg/1 tablettablet · extended-releasePRAMIPEXOL CINFA
AU 26 records · 10 strengths
- 0.375 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 0.75 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 1.5 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 0.25 mgtabletAPO-PramipexoleSIFROL ER、Simipex 0.25、Simpral
- 1 mgtabletAPO-PramipexoleSIFROL ER、Simipex 1、Simpral
- 0.125 mgtabletAPO-PramipexoleSIFROL ER、Simipex 0.125、Simpral
- 4.5 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 3.75 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 3 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
- 2.25 mgtablet · extended-releaseSIFROL ERSIMIPEX XR
HK 14 records · 1 strengths
Records without a stated strength · 1 APO-Pramipexole、APT-PRAMIPEXOLE EXTENDED-RELEASE TABLETS 0.375MG、MIRAPEX、PMS-PRAMIPEXOLE、PRAMEXOL 0.25 TABLETS 0.25MG、PRAMEXOL 1 TABLETS 1MG
TW 13 records · 5 strengths
- 0.375 mgtablet · extended-releaseMirapex 0.75mg prolonged-release tabletsMixole prolonged-release tablets 0.375 mg、Zonimide Prolonged Release Tablets 0.375 mg、平巴持續性藥效錠0.375毫克、樂伯克持續性藥效錠0.375毫克、立鎮安持續性藥效錠0.375毫克
- 0.75 mgtablet · extended-releaseMirapex 0.75mg prolonged-release tabletsMixole prolonged-release tablets 0.375 mg、Zonimide Prolonged Release Tablets 0.375 mg、平巴持續性藥效錠0.75毫克、樂伯克持續性藥效錠0.75毫克、立鎮安持續性藥效錠0.75毫克
- 1.5 mgtablet · extended-releaseMirapex 0.75mg prolonged-release tabletsMixole prolonged-release tablets 0.375 mg、Zonimide Prolonged Release Tablets 0.375 mg、平巴持續性藥效錠1.5毫克、樂伯克持續性藥效錠1.5毫克、立鎮安持續性藥效錠1.5毫克
- 0.25 mgtablet"五洲"巴森錠0.25毫克APO-Pramipexole、MIRAPEX、PEXO Tablets 1mg、安保穩樂錠0.25毫克、樂伯克錠 0.25公絲
- 1 mgtablet"五洲"巴森錠1毫克PEXO Tablets 1mg
EU 4 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Mirapexin 0.7mg tablets、Oprymea 0.088mg tablets、Pramipexole Teva、SIFROL ER
SG 1 records · 1 strengths
- 0.125 mgtabletSIFROL ER
MX 1 records · 1 strengths
- 0.5 mgtabletEXOAURO
| Strength / form / release | GB | AU | SG | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 0.375 mgRecorded as: 375 microgram tablet · extended-release | SIFROL ER SIMIPEX XR | Manufacturer: MacleodsPharmaceuticalsLtd ×3 Manufacturer: 力品药业(厦门)股份有限公司 ×4 Manufacturer: 北京北大维信生物科技有限公司 ×3+15Manufacturer: 北京北陆药业股份有限公司 ×2 Manufacturer: 天津红日药业股份有限公司 ×4 Manufacturer: 山东华铂凯盛生物科技有限公司 ×6 Manufacturer: 成都倍特药业股份有限公司 ×2 Manufacturer: 成都康弘药业集团股份有限公司 ×2 Manufacturer: 成都百裕制药股份有限公司 ×3 Manufacturer: 扬子江药业集团有限公司 Manufacturer: 江苏恒瑞医药股份有限公司 ×2 Manufacturer: 浙江京新药业股份有限公司 ×7 Manufacturer: 海思科制药(眉山)有限公司 ×2 Manufacturer: 深圳翰宇药业股份有限公司 Manufacturer: 石药集团欧意药业有限公司 ×9 Manufacturer: 陕西步长高新制药有限公司 ×3 Manufacturer: 齐鲁制药(海南)有限公司 ×6 森福罗盐酸普拉克索 | Mirapex 0.75mg prolonged-release tablets Mixole prolonged-release tablets 0.375 mg Zonimide Prolonged Release Tablets 0.375 mg | ||||||
| 0.75 mgRecorded as: 750 microgram tablet · extended-release | SIFROL ER SIMIPEX XR | Manufacturer: MacleodsPharmaceuticalsLtd ×3 Manufacturer: 力品药业(厦门)股份有限公司 ×4 Manufacturer: 北京北大维信生物科技有限公司 ×3+9Manufacturer: 北京北陆药业股份有限公司 ×2 Manufacturer: 山东华铂凯盛生物科技有限公司 ×6 Manufacturer: 成都百裕制药股份有限公司 ×3 Manufacturer: 江苏恒瑞医药股份有限公司 ×2 Manufacturer: 浙江京新药业股份有限公司 ×7 Manufacturer: 湖南九典制药股份有限公司 ×2 Manufacturer: 石药集团欧意药业有限公司 ×9 Manufacturer: 齐鲁制药(海南)有限公司 ×6 森福罗盐酸普拉克索 | Mirapex 0.75mg prolonged-release tablets Mixole prolonged-release tablets 0.375 mg Zonimide Prolonged Release Tablets 0.375 mg | ||||||
| 1.5 mg tablet · extended-release | SIFROL ER SIMIPEX XR | Manufacturer: MacleodsPharmaceuticalsLtd ×3 Manufacturer: 北京北大维信生物科技有限公司 ×3 Manufacturer: 天津红日药业股份有限公司 ×4+5Manufacturer: 成都倍特药业股份有限公司 ×2 Manufacturer: 成都康弘药业集团股份有限公司 ×2 Manufacturer: 成都百裕制药股份有限公司 ×3 Manufacturer: 海思科制药(眉山)有限公司 ×2 Manufacturer: 石药集团欧意药业有限公司 ×9 | Mirapex 0.75mg prolonged-release tablets Mixole prolonged-release tablets 0.375 mg Zonimide Prolonged Release Tablets 0.375 mg | ||||||
| 0.25 mgRecorded as: 250 microgram tablet | APO-Pramipexole SIFROL ER Simipex 0.25+1Simpral | Manufacturer: 天津红日药业股份有限公司 ×4 Manufacturer: 浙江京新药业股份有限公司 ×7 Manufacturer: 石药集团欧意药业有限公司 ×9+2Manufacturer: 齐鲁制药(海南)有限公司 ×6 森福罗盐酸普拉克索 | "五洲"巴森錠0.25毫克 APO-Pramipexole MIRAPEX | ||||||
| 2.1 mg tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets PRAMIPEXOL AUROVITAS SPAIN | |||||||
| 1.05 mg tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets PRAMIPEXOL AUROVITAS SPAIN | |||||||
| 1 mg tablet | APO-Pramipexole SIFROL ER Simipex 1+1Simpral | Manufacturer: 天津红日药业股份有限公司 ×4 Manufacturer: 浙江京新药业股份有限公司 ×7 Manufacturer: 石药集团欧意药业有限公司 ×9+2Manufacturer: 齐鲁制药(海南)有限公司 ×6 森福罗盐酸普拉克索 | "五洲"巴森錠1毫克 PEXO Tablets 1mg | ||||||
| 0.26 mg tablet · extended-release | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets PRAMIPEXOL AUROVITAS SPAIN | ||||||||
| 2.62 mg tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets+2Pipexus 1.05mg modified-release tablets Sifrol 2.62mg modified-release tablets | Oprymea 0.088mg tablets PRAMIPEXOL CINFA PRAMIPEXOL NORMON | |||||||
| 1.57 mg tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets | Oprymea 0.088mg tablets PRAMIPEXOL CINFA PRAMIPEXOL NORMON | |||||||
| 0.18 mg tablet | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets PRAMIPEXOL KERN PHARMA | ||||||||
| 3.15 mg tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets | Oprymea 0.088mg tablets PRAMIPEXOL NORMON | |||||||
| 0.7 mg tablet | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets PRAMIPEXOL KERN PHARMA | ||||||||
| 0.125 mgRecorded as: 125 microgram tablet | APO-Pramipexole SIFROL ER Simipex 0.125+1Simpral | SIFROL ER | |||||||
| 0.52 mg tablet · extended-release | Oprymea 0.088mg tablets PRAMIPEXOL CINFA PRAMIPEXOL NORMON | ||||||||
| 4.5 mg tablet · extended-release | SIFROL ER SIMIPEX XR | ||||||||
| 3.75 mg tablet · extended-release | SIFROL ER SIMIPEX XR | ||||||||
| 3 mg tablet · extended-release | SIFROL ER SIMIPEX XR | ||||||||
| 2.25 mg tablet · extended-release | SIFROL ER SIMIPEX XR | ||||||||
| 0.7 mg/1 tablet tablet | PRAMIPEXOL AUROVITAS PRAMIPEXOL CINFA | ||||||||
| 0.18 mg/1 tablet tablet | PRAMIPEXOL AUROVITAS PRAMIPEXOL CINFA | ||||||||
| 3.15 mg/1 tablet tablet · extended-release | PRAMIPEXOL CINFA | ||||||||
| 0.5 mg tablet | EXOAURO | ||||||||
unknown | APO-Pramipexole APT-PRAMIPEXOLE EXTENDED-RELEASE TABLETS 0.375MG MIRAPEX+3PMS-PRAMIPEXOLE PRAMEXOL 0.25 TABLETS 0.25MG PRAMEXOL 1 TABLETS 1MG | Mirapexin 0.7mg tablets Oprymea 0.088mg tablets Pramipexole Teva | |||||||
tablet · extended-release | No trade name Mirapexin 0.26mg modified-release tablets Oprymea 0.26mg modified-release tablets | ||||||||
tablet | No trade name Mirapexin 0.7mg tablets Neliprax 0.088mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
7 more strength/form rows are recorded only in AU · SG · MX · HK · EU and are not shown in this table. Hay 7 filas de concentración/forma registradas solo en AU · SG · MX · HK · EU que no se muestran en esta tabla. 另有 7 个规格/剂型仅在 AU · SG · MX · HK · EU 有记录(未在本表显示)。 另有 7 個規格/劑型僅在 AU · SG · MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.